THERAVECTYS to Present Detailed Phase I/II Results from the First-Ever Lentiviral-Vector Based Therapeutic Vaccine Trial ...
World News Network,
PARIS--(BUSINESS WIRE)--THERAVECTYS, a French Biotech company developing immunotherapies, presents today the detailed results…